Clonal Hematopoiesis Rates in a Recurrent Venous Thrombosis Population: A Prospective Pilot Study

Tamanna Haque, Arletta Lozanski, Tzy-Jyye Doong, Ying Huang, Rui Li, Abigail Bartosic, Kristina Landes, Gerard Lozanski, John C. Byrd, Tzu-Fei Wang, Division of Hematology, Department of Medicine, The Ohio State Wexner Medical Center, Comprehensive Cancer Center, The Ohio State Wexner Medical Center, Division of Pathology, The Ohio State Wexner Medical Center, Department of Medicine, University of Cincinnati, Department of Medicine, University of Ottawaat The Ottawa Hospital and Ottawa Hospital Research Institute

Clinical and Applied Thrombosis/Hemostasis

Published online on May 21, 2026

Abstract

Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
BackgroundApproximately 50% of venous thromboembolism (VTE) are unprovoked, and 30% recur, leading to significant patient morbidity. Clonal hematopoiesis (CH) are acquired hematopoietic mutations that increase the risk of cardiovascular disease and ...